2,779
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Are emerging PGD2 antagonists a promising therapy class for treating asthma?

, &
Pages 359-364 | Received 15 Aug 2016, Accepted 28 Sep 2016, Published online: 16 Oct 2016
 

Declaration of interest

S Johnston is a National Institute of Health Research Senior Investigator. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

H Farne was supported by a Medical Research Council Programme Grant (MR/M025330). S Johnston is supported by an Asthma UK Chair (CH11SJ) and a Medical Research Council Centre Grant (G1000758).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.